INNOVACAP Share Price
INNOVACAP Share Price Today
As of 5 Jul 2026, INNOVACAP share price is ₹957.85. The stock opened at ₹989.90, compared to its previous close of ₹980.10. During today's trading session, INNOVACAP share price moved in the range of ₹953.00 to ₹992.45, with an average price of ₹972.73 for the day. Looking at its last 52-week, the stock has touched a low of ₹622.00 and a high of ₹1,031.50. On the performance front, INNOVACAP share price has increased by 32.09% over the last six months and is up 11.89% on a year-on-year basis.
INNOVACAP Returns Calculator
INNOVACAP Shareholder Returns
INNOVACAP Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
INNOVACAP Financials
Income Statement · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹1,630.02 | ₹1,243.68 | ₹1,081.31 | ₹926.38 |
| Other Income | ₹7.42 | ₹12.05 | ₹12.49 | ₹9.20 |
| Total Revenue | ₹1,637.44 | ₹1,255.72 | ₹1,093.79 | ₹935.58 |
| Total Expenses | ₹1,449.17 | ₹1,084.71 | ₹964.27 | ₹843.78 |
| Profit Before Tax | ₹188.26 | ₹171.02 | ₹129.53 | ₹91.80 |
| Tax | ₹47.35 | ₹42.76 | ₹35.18 | ₹23.84 |
| Profit After Tax | ₹140.92 | ₹128.26 | ₹94.35 | ₹67.95 |
| EPS - Basic | ₹24.63 | ₹22.41 | ₹18.66 | ₹14.16 |
| EPS - Diluted | ₹24.63 | ₹22.41 | ₹18.66 | ₹14.16 |
Cash Flow · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹188.26 | ₹171.02 | ₹129.53 | ₹91.80 |
| Income before WC changes | ₹245.90 | ₹198.40 | ₹166.69 | ₹117.71 |
| Change in Assets | -₹224.54 | -₹140.14 | ₹11.43 | -₹46.98 |
| Change in Liabilities | ₹121.41 | ₹29.30 | -₹4.11 | ₹15.92 |
| Change in WC | -₹103.13 | -₹110.84 | ₹7.31 | -₹31.06 |
| Cash flow from Operations | ₹116.52 | ₹63.84 | ₹146.34 | ₹67.12 |
| Cash flow from Investing | -₹107.12 | -₹151.59 | -₹498.97 | -₹90.84 |
| Cash flow from Financing | -₹21.72 | ₹91.53 | ₹360.83 | ₹27.09 |
| Total Cash Flow | -₹12.32 | ₹3.79 | ₹8.20 | ₹3.37 |
| Cash (Start of the year) | ₹15.52 | ₹11.73 | ₹3.53 | ₹0.15 |
| Cash (End of the year) | ₹3.20 | ₹15.52 | ₹11.73 | ₹3.53 |
Balance Sheet · Consolidated
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹914.42 | ₹884.71 | ₹741.13 | ₹261.95 |
| Current Assets | ₹922.96 | ₹695.69 | ₹579.75 | ₹442.47 |
| Total Assets | ₹1,837.38 | ₹1,580.41 | ₹1,320.88 | ₹704.41 |
| Current Liabilities | ₹494.58 | ₹353.00 | ₹265.48 | ₹277.55 |
| Net Current Asset | ₹428.38 | ₹342.69 | ₹314.27 | ₹164.92 |
| Non-Current Liabilities | ₹252.01 | ₹267.99 | ₹224.51 | ₹150.36 |
| Equity Capital | ₹1,090.79 | ₹959.42 | ₹830.89 | ₹276.51 |
| Total Equity & Liabilities | ₹1,837.38 | ₹1,580.41 | ₹1,320.88 | ₹704.41 |
Income Statement · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Revenue | ₹1,298.81 | ₹958.06 | ₹864.93 | ₹858.67 |
| Other Income | ₹13.24 | ₹16.78 | ₹10.72 | ₹8.73 |
| Total Revenue | ₹1,312.06 | ₹974.84 | ₹875.65 | ₹867.41 |
| Total Expenses | ₹1,200.24 | ₹854.95 | ₹781.95 | ₹789.10 |
| Profit Before Tax | ₹111.82 | ₹119.89 | ₹93.70 | ₹78.31 |
| Tax | ₹28.13 | ₹30.42 | ₹25.54 | ₹20.76 |
| Profit After Tax | ₹83.69 | ₹89.47 | ₹68.16 | ₹57.55 |
| EPS - Basic | ₹14.63 | ₹15.63 | ₹13.48 | ₹11.99 |
| EPS - Diluted | ₹14.63 | ₹15.63 | ₹13.48 | ₹11.99 |
Cash Flow · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Profit before tax | ₹111.82 | ₹119.89 | ₹93.70 | ₹78.31 |
| Income before WC changes | ₹152.93 | ₹129.27 | ₹116.01 | ₹101.89 |
| Change in Assets | -₹217.99 | -₹115.03 | ₹11.39 | -₹51.98 |
| Change in Liabilities | ₹119.74 | ₹24.95 | ₹8.26 | ₹8.28 |
| Change in WC | -₹98.25 | -₹90.08 | ₹19.65 | -₹43.70 |
| Cash flow from Operations | ₹34.11 | ₹19.80 | ₹111.67 | ₹39.28 |
| Cash flow from Investing | -₹14.06 | -₹99.75 | -₹471.55 | -₹87.53 |
| Cash flow from Financing | -₹33.99 | ₹83.86 | ₹368.13 | ₹51.29 |
| Total Cash Flow | -₹13.94 | ₹3.92 | ₹8.25 | ₹3.03 |
| Cash (Start of the year) | ₹15.31 | ₹11.39 | ₹3.14 | ₹0.10 |
| Cash (End of the year) | ₹1.37 | ₹15.31 | ₹11.39 | ₹3.14 |
Balance Sheet · Standalone
| Particulars | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Non-Current Assets | ₹797.26 | ₹836.04 | ₹717.63 | ₹299.96 |
| Current Assets | ₹749.83 | ₹529.11 | ₹437.44 | ₹378.38 |
| Total Assets | ₹1,547.09 | ₹1,365.14 | ₹1,155.07 | ₹678.34 |
| Current Liabilities | ₹414.25 | ₹290.16 | ₹213.40 | ₹259.32 |
| Net Current Asset | ₹335.58 | ₹238.94 | ₹224.04 | ₹119.06 |
| Non-Current Liabilities | ₹246.18 | ₹262.02 | ₹217.95 | ₹150.70 |
| Equity Capital | ₹886.65 | ₹812.97 | ₹723.72 | ₹268.32 |
| Total Equity & Liabilities | ₹1,547.09 | ₹1,365.14 | ₹1,155.07 | ₹678.34 |
About INNOVACAP
Innova Captab Limited is an integrated pharmaceutical company. The Company is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. It has a presence across the pharmaceuticals value chain, including research and development, manufacturing, drug distribution and marketing and exports. Its business includes Contract Development and Manufacturing (CDMO) Services and Products, Domestic Branded Generics, and International Branded Generics. Its CDMO business provides research, product development and manufacturing services. Its Branded Generics business consists of the development, manufacture and distribution of generic formulation products, which are marketed and distributed in India under its own brand names through online and offline channels. Its generic drug products are also available online through various e-commerce pharmacy sites. It has developed a diversified branded generics product portfolio including tablets, capsules, dry syrups, and others.
INNOVACAP Financial Highlights
- Revenue: INNOVACAP reported revenue of ₹1,637.44 crore in FY26 vs ₹1,255.73 crore in FY25. It showed an increase of 30.40% on a yearly basis.
- Operating Profit: INNOVACAP reported an operating profit of ₹188.26 crore in FY26 vs ₹171.02 crore in FY25. It showed an increase of 10.08% on a year-on-year basis.
- Net Profit: INNOVACAP reported a net profit of ₹140.92 crore in FY26 vs ₹128.26 crore in FY25. It showed an increase of 9.87% on a yearly basis.
INNOVACAP Quarterly Result Highlights
- INNOVACAP reported revenue of ₹449.36 crore in Mar 2026, compared with ₹451.94 crore in Dec 2025, representing a decrease of 0.57% on a quarter-on-quarter (QoQ) basis.
- INNOVACAP reported an operating profit of ₹50.68 crore in Mar 2026, compared with ₹55.68 crore in Dec 2025, representing a decrease of 8.98% on a quarter-on-quarter (QoQ) basis.
- INNOVACAP reported a profit of ₹38.08 crore in Mar 2026, compared with ₹42.15 crore in Dec 2025, reflecting a decrease of 9.66% on a QoQ basis.
- The earnings per share (EPS) of INNOVACAP stood at ₹24.63 during Mar 2026.
Similar Stocks
FAQs on INNOVACAP Share Price
What is INNOVACAP share price today?
INNOVACAP share price is ₹957.85 as on 03 Jul, 2026, 15:45 IST.
How has the INNOVACAP share price performed in the past?
In the last 1 year, INNOVACAP delivered a return of 11.89%. The INNOVACAP share price hit a high of ₹1,031.50 and low of ₹622.00.
How much is the Mutual Fund shareholding in INNOVACAP shares?
The Mutual Fund Shareholding in INNOVACAP was 10.50% at the end of Mar 2026.
What is the the 52-week high and low of INNOVACAP shares ?
The 52-week high and low of INNOVACAP share is ₹1,031.50 and ₹622.00 as of 03 Jul, 2026.
What is the market cap of INNOVACAP?
The market capitalisation of INNOVACAP is ₹5,604.61 Crores as on 03 Jul, 2026.
What are the stock symbols of INNOVACAP?
The stock symbol of INNOVACAP is INNOVACAP on the NSE, 544067 on the BSE, and the ISIN is INE0DUT01020.
What was yesterday's closing price of INNOVACAP shares ?
INNOVACAP shares closed yesterday at ₹980.10 on NSE & ₹979.40 on BSE
How to buy INNOVACAP shares?
To buy INNOVACAP shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy INNOVACAP shares on Holidays?
No, shares of INNOVACAP or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell INNOVACAP shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of INNOVACAP?
The PE and PB ratio of INNOVACAP is 27.91 and 3.61 respectively, as on 03 Jul, 2026, 15:45 IST.